Trump Fast-Tracks Psychedelic Treatments, Calls It “New Hope" for Veterans.

April 17th,

Obesity Drug Market Faces Uncertainty as GLP-1 Prices Drop.

February 3rd,

Article: The global obesity drug market faces a period of uncertainty as prices for GLP-1 treatments from Novo Nordisk and Eli Lilly decline sharply in the United States. Once projected to reach $150 billion b

Trump Mocks Ozempic After Claiming Drug Failed a Powerful Friend.

January 18th,

Article: President Donald Trump sparked renewed discussion around popular weight-loss medications after sharing a blunt anecdote during a January 16, 2026 speech in Florida. In his trademark unscripted style,